Alchemy Investments Acquisition Corp 1 (ALCYF) Stock Price & Analysis
Alchemy Investments Acquisition Corp 1 (ALCYF) rose 0.00% to USD 12 as of July 26, 2026 at 06:14 UTC, according to Nexqual real-time market data.
ALCYF last closed at USD 12; the session ranged USD 11.71–11.71 on volume of 2 shares. Market capitalization is $50.50M, with a 52-week range of USD 10.25–15.9 (PNK). Source: Nexqual, July 26, 2026 at 06:14 UTC.
Key Statistics (as of July 26, 2026 at 06:14 UTC)
| Price | USD 12 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 12 |
| Open | USD 11.71 |
| Day Range | USD 11.71 – 11.71 |
| 52-Week Range | USD 10.25 – 15.9 |
| Volume | 2 shares |
| Market Cap | $50.50M |
| Exchange | PNK |
Technical Analysis (ALCYF)
Nexqual's technical model rates ALCYF "BUY" based on 5 bullish and 1 bearish signals across 125 daily candles, as of July 26, 2026 at 06:14 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 63.29 (neutral) |
| vs SMA50 | Above (USD 11.84) |
| MACD | 0.04 (positive) |
Analyst Ratings (ALCYF)
Wall Street analysts rate ALCYF "None", per Nexqual as of July 26, 2026 at 06:14 UTC.
| Consensus Rating | None |
|---|
Earnings (ALCYF)
Source: Nexqual, July 26, 2026 at 06:14 UTC.
Financials & Fundamentals (ALCYF)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.04 |
| Total Cash | $86,243 |
| Total Debt | $2.00M |
| Free Cash Flow | $-259,945 |
Source: Nexqual, July 26, 2026 at 06:14 UTC.
Financial Health Score (ALCYF)
Nexqual rates Alchemy Investments Acquisition Corp 1's overall financial health "Weak" across five dimensions, as of July 26, 2026 at 06:14 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $86K cash vs $2M debt |
| Cash Flow | Weak — Operating cash flow -$1M |
| Efficiency | Mixed — No data |
Ownership (ALCYF)
| Insider Ownership | +81.11% |
|---|---|
| Institutional Ownership | +5.23% |
| Shares Outstanding | 4.21M |
| Float | 795,026 |
| Short % of Float | +0.67% |
Source: Nexqual, July 26, 2026 at 06:14 UTC.
Leadership (ALCYF)
Alchemy Investments Acquisition Corp 1 is led by Vittorio Savoia (age 37), Co-CEO & Director, per Nexqual as of July 26, 2026 at 06:14 UTC.
| Co-CEO & Director | Vittorio Savoia (age 37) |
|---|---|
| Co-CEO & Director | Mattia Tomba (age 48) |
| Chief Financial Officer | Harshana Sidath Jayaweera (age 44) |
Major Backers & Investors (ALCYF)
Notable institutional backers of Alchemy Investments Acquisition Corp 1 include Clear Street Group Inc., AQR Arbitrage LLC, CALAMOS INVESTMENT TRUST/IL-Calamos Market Neutral Income Fund, according to Nexqual as of July 26, 2026 at 06:14 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Clear Street Group Inc. | 2.36% |
| AQR Arbitrage LLC | 2.02% |
| CALAMOS INVESTMENT TRUST/IL-Calamos Market Neutral Income Fund | 1.67% |
| Calamos Advisors LLC | 1.64% |
| Toronto Dominion Bank | 1.43% |
| Polar Asset Management Partners Inc. | 1.26% |
| Periscope Capital Inc. | 1.12% |
| Shay Capital LLC | 0.69% |
Source: Nexqual, July 26, 2026 at 06:14 UTC.
From Alchemy Investments Acquisition Corp 1's Latest SEC 10-K Filing (filed 2026-04-09)
Key Strengths & Strategy (as disclosed to the SEC)
- Alchemy Investments Acquisition Corp 1 does not have significant operations.
- It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AFJK | Aimei Health Technology Co., Lt | USD 11.76 | ▼ 2% |
| ANSC | Agriculture & Natural Solutions | USD 11.45 | ▲ 0% |
| AFRI | Forafric Global PLC | USD 10.51 | ▼ 0.76% |
| ABLV | Able View Global Inc. | USD 0.93 | ▲ 0% |
| ABTS | Abits Group Inc | USD 1.14 | ▼ 10.94% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 06:14 UTC. This page is informational and not investment advice.